Legal victory reported for UC and a UCLA faculty member

Inside Higher Ed is reporting a legal victory by the Regents concerning two prostate cancer drugs. The sequence of events and the details of the suits and counter-suits are not clear from the article but at least one of the drugs involved appears to have been developed at UCLA. Part of the litigation referenced involved clearing a UCLA faculty member of defrauding a drug company.

A long-running dispute over licensing of prostate cancer drugs has ended in the University of California’s favor.

California’s Supreme Court last week upheld lower court rulings in favor of the University of California Board of Regents. The decision effectively awards the university $32 million in additional licensing income while also resolving contract claims against the regents and confirming a jury verdict clearing a drug inventor of fraud...

Full story at https://www.insidehighered.com/quicktakes/2016/12/21/uc-regents-win-prostate-cancer-drug-rulings